NO20044628L - Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler - Google Patents

Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler

Info

Publication number
NO20044628L
NO20044628L NO20044628A NO20044628A NO20044628L NO 20044628 L NO20044628 L NO 20044628L NO 20044628 A NO20044628 A NO 20044628A NO 20044628 A NO20044628 A NO 20044628A NO 20044628 L NO20044628 L NO 20044628L
Authority
NO
Norway
Prior art keywords
cell surface
containing cell
surface recognition
immunoglobulin domains
recognition molecules
Prior art date
Application number
NO20044628A
Other languages
English (en)
Norwegian (no)
Inventor
Christine Power
Andrew Robert Davids
Richard Joseph Fagan
Christopher Benjamin Phelps
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of NO20044628L publication Critical patent/NO20044628L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Plant Pathology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
NO20044628A 2002-04-30 2004-10-27 Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler NO20044628L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0209884.6A GB0209884D0 (en) 2002-04-30 2002-04-30 Proteins
PCT/GB2003/001851 WO2003093316A2 (fr) 2002-04-30 2003-04-30 Molecule a reconnaissance de la surface des cellules contenant un domaine d'immunoglobuline

Publications (1)

Publication Number Publication Date
NO20044628L true NO20044628L (no) 2004-12-29

Family

ID=9935806

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044628A NO20044628L (no) 2002-04-30 2004-10-27 Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler

Country Status (16)

Country Link
US (1) US7622555B2 (fr)
EP (1) EP1499640A2 (fr)
JP (1) JP2006502702A (fr)
KR (1) KR20050008699A (fr)
CN (1) CN1665840A (fr)
AU (1) AU2003229961B2 (fr)
BR (1) BR0309638A (fr)
CA (1) CA2483038A1 (fr)
EA (1) EA007985B1 (fr)
GB (1) GB0209884D0 (fr)
IL (1) IL164777A0 (fr)
MX (1) MXPA04010674A (fr)
NO (1) NO20044628L (fr)
RS (1) RS92704A (fr)
WO (1) WO2003093316A2 (fr)
ZA (1) ZA200408453B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0326393D0 (en) * 2003-11-12 2003-12-17 Ares Trading Sa Cytokine antagonist molecules
US20080193414A1 (en) * 2005-05-06 2008-08-14 Amanda Proudfoot Use of an Immunoglobulin Domain-Containing Cell Surface Recognition Molecule For Treating Diseases
CN100402551C (zh) * 2006-04-14 2008-07-16 中国科学院长春应用化学研究所 β2-微球蛋白的抗原表位及应用
RU2009109355A (ru) 2006-08-17 2010-09-27 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Ингибиторы вырусной полимеразы
PL2164514T3 (pl) 2007-05-21 2017-08-31 Alderbio Holdings Llc Przeciwciała przeciwko IL-6 i ich zastosowanie
US8252286B2 (en) 2007-05-21 2012-08-28 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8062864B2 (en) 2007-05-21 2011-11-22 Alderbio Holdings Llc Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US8178101B2 (en) 2007-05-21 2012-05-15 Alderbio Holdings Inc. Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
US8404235B2 (en) 2007-05-21 2013-03-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US7906117B2 (en) * 2007-05-21 2011-03-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US8337847B2 (en) 2008-11-25 2012-12-25 Alderbio Holdings Llc Methods of treating anemia using anti-IL-6 antibodies
US8323649B2 (en) 2008-11-25 2012-12-04 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US8420089B2 (en) 2008-11-25 2013-04-16 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
KR20120118088A (ko) 2009-11-24 2012-10-25 앨더바이오 홀딩스 엘엘씨 Ⅰｌ-6에 대한 항체 및 이들의 용도
AU2011332817A1 (en) 2010-11-23 2013-06-13 Alder Biopharmaceuticals, Inc. Anti-IL-6 antibodies for the treatment of anemia
CN107526942B (zh) * 2017-07-18 2021-04-20 中山大学 生命组学序列数据的反向检索方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420526B1 (en) * 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
GB2331666A (en) * 1997-11-20 1999-05-26 Dsc Telecom Lp Subscriber Terminal for a Wireless Telecommunications System
US6783961B1 (en) * 1999-02-26 2004-08-31 Genset S.A. Expressed sequence tags and encoded human proteins
CA2296792A1 (fr) 1999-02-26 2000-08-26 Genset S.A. Sequences marqueurs exprimees et proteines humaines codees
EP1285084A1 (fr) * 2000-01-25 2003-02-26 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
EP1385883A2 (fr) * 2000-10-27 2004-02-04 Incyte Genomics, Inc. Proteines transmembranes
EP1399554A2 (fr) * 2000-11-16 2004-03-24 Incyte Genomics, Inc. Proteines de la superfamille des immunoglobulines
US20070141566A1 (en) 2002-07-12 2007-06-21 Fabio Rupp Methods and materials relating to novel polypeptides and polynucleotides
EP1556490A4 (fr) 2002-10-22 2006-04-05 Nuvelo Inc Nouveaux acides nucleiques et polypeptides

Also Published As

Publication number Publication date
CN1665840A (zh) 2005-09-07
MXPA04010674A (es) 2005-02-17
WO2003093316A3 (fr) 2004-02-12
KR20050008699A (ko) 2005-01-21
EA200401453A1 (ru) 2005-06-30
GB0209884D0 (en) 2002-06-05
BR0309638A (pt) 2005-03-01
CA2483038A1 (fr) 2003-11-13
EP1499640A2 (fr) 2005-01-26
IL164777A0 (en) 2005-12-18
ZA200408453B (en) 2006-07-26
US7622555B2 (en) 2009-11-24
WO2003093316A2 (fr) 2003-11-13
AU2003229961A1 (en) 2003-11-17
RS92704A (en) 2006-12-15
AU2003229961B2 (en) 2009-02-19
US20040204352A1 (en) 2004-10-14
EA007985B1 (ru) 2007-02-27
JP2006502702A (ja) 2006-01-26

Similar Documents

Publication Publication Date Title
NO20044628L (no) Immunglobulindomene som inneholder celleoverflategjenkjennende molekyler
US20230236198A1 (en) Kits for analysis using nucleic acid encoding and/or label
WO2019089846A1 (fr) Méthodes et compositions pour analyse de polypeptides
DK1673475T3 (da) Sammensætninger til diagnose og terapi af sygdomme, som er forbundet med aberrant ekspression af futriner (R-Spondiner) og/eller Wnt
NO20070757L (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
EP3962930A1 (fr) Procédés et réactifs pour le clivage de l'acide aminé n-terminal d'un polypeptide
NO20052956L (no) Defensinprotiner
WO2006046073A3 (fr) Proteine du type c1q
MX2007005054A (es) Proteinas que contienen el factor a de von willebrand y dominios extracelulares del receptor de antrax.
WO2004076614A3 (fr) Sequences d'acide nucleique humaines issues de carcinomes de la prostate
DE602004029061D1 (de) Zusammensetzungen, reagenzien, kits und verfahren für die diagnose und behandlung von fettleibigkeit und/oder diabetes
NO20070780L (no) Celloverflateprotein.
ATE442382T1 (de) Ein die mam-domäne enthaltendes protein
ATE512983T1 (de) Rezeptor für das tgr3-like protein
WO2007049065A3 (fr) Proteine contenant des domaines vwfa, collagene et kunitz
NO20053512L (no) IL-8-liknende proteiner
EA200600956A1 (ru) Молекулы-антагонисты цитокинов
ATE402948T1 (de) Verfahren zur aufreinigung eines nichtimmunoglobulinproteins, das eine immunoglobulinähnliche (ig-like) domäne enthält
NO20053574L (no) Spleisevarianter av LGR6
WO2007068913A3 (fr) Protéines contenant le domaine SRCR-B
NO20052958L (no) Spleisevariant av humant placentalt veksthormon
DE602004024300D1 (de) Anti-BAMBI Antikörper oder RNA zur Diagnose und Therapie bei Dickdarm- oder Leberkrebs
WO2004009633A8 (fr) Recepteur de serotonine
ATE340804T1 (de) Hyphenspezifische faktoren aus candida albicans
ATE361983T1 (de) Für eine phosphomevalonatkinase (pmk) kodierendes gen erg8 aus candida albicans

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application